Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
En mme temps, il favorise la thermogense, cest--dire la consommation dnergie par lorganisme, et a un effet antioxydant
The question of whether this translates directly to humans is still being studied, but the neuroanatomical overlap is significant
Why Patients Are Excited About Retatrutide Retatrutide is designed to support healthy weight loss by helping manage appetite, reduce cravings, and promote a greater feeling of fullness